Dr. Lalit Kumar

• Dr. Lalit Kumar is a highly regarded BMT specialist with extensive expertise in the field of bone marrow transplantation.
• He has a strong educational background, including medical school and specialized training in hematology and BMT procedures.
• Dr. Kumar is dedicated to providing comprehensive care to patients who require bone marrow transplants due to conditions like leukemia, lymphoma, and other blood-related disorders.
• He remains at the forefront of medical advancements in the field of BMT, incorporating the latest techniques and research into his practice.
• Dr. Kumar collaborates closely with a team of medical professionals, including hematologists, oncologists, and transplant coordinators, to offer a multidisciplinary approach to patient care.
• He is known for his compassionate and patient-centric approach, providing emotional support to patients and their families during the challenging BMT journey.

Dr. Lalit Kumar actively participates in clinical trials and research, contributing to the development of improved BMT procedures and post-transplant care.

He educates his patients about the BMT process, potential risks, and expected outcomes, ensuring they make informed decisions about their treatment.

Dr. Kumar emphasizes the importance of donor matching, pre-transplant conditioning, and post-transplant care to enhance the chances of a successful transplant.

His dedication to improving the lives of patients in need of bone marrow transplants and his significant contributions to the field of BMT make Dr. Lalit Kumar a respected figure in the medical community.

Experience of Dr. Lalit Kumar

He has many  years of experience in this field.

• MBBS & MD (Medicine) – Sarojini Naidu Medical College, Agra
• DM Medical Oncology – Adyar Cancer Institute, Chennai
• Post-Doctoral Fellowship – Royal Postgraduate Medical School of the Hammersmith Hospital, London
• Fulbright Scholarship – United States of America

• Bone Marrow  Transplantation
• Cancer Care
• Oncology

•  Indo British Health Initiative (IBHI)
• Institute of Women’s Health (IFWH) of the University College of London (UCL)
• Expert Committee to examine the Serious Adverse Events (SAE) of deaths occurring during clinical trials

• English
• Hindi